Taylor Cath, Finnegan-John Jennifer, Green James S A
BMC Health Serv Res. 2014 Oct 24;14:488. doi: 10.1186/s12913-014-0488-2.
Cancer care is commonly managed by multidisciplinary teams (MDTs) who meet to discuss and agree treatment for individual patients. Patients do not attend MDT meetings but recommendations for treatments made in the meetings directly influence the decision-making process between patients and their responsible clinician. No research to-date has considered patient perspectives (or understanding) regarding MDTs or MDT meetings, though research has shown that failure to consider patient-based information can lead to recommendations that are inappropriate or unacceptable, and can consequently delay treatment.
Semi-structured interviews were conducted with current cancer patients from one cancer centre who had either upper gastrointestinal or gynaecological cancer (n = 9) and with MDT members (n = 12) from the teams managing their care. Interview transcripts were analysed thematically using Framework approach. Key themes were identified and commonalities and discrepancies within and between individual transcripts and within and between patient and team member samples were identified and examined using the constant comparative method.
Patients had limited opportunities to input to or influence the decision-making process in MDT meetings. Key explanatory factors included that patients were given limited and inconsistent information about MDTs and MDT meetings, and that MDT members had variable definitions of patient-centredness in the context of MDTs and MDT meetings. Patients that had knowledge of medicine (through current/previous employment themselves or that of a close family member) appeared to have greater understanding and access to the MDT. Reassurance emerged as a 'benefit' of informing patients about MDTs and MDT meetings.
There is a need to ensure MDT processes are both efficient and patient-centred. The operationalization of "No decision about me without me" in the context of MDT models of care - where patients are not present when recommendations for treatment are discussed - requires further consideration. Methods for ensuring that patients are actively integrated into the MDT processes are required to ensure patients have an informed choice regarding engagement, and to ensure recommendations are based on the best available patient-based and clinical evidence.
癌症护理通常由多学科团队(MDT)管理,这些团队会开会讨论并商定针对个体患者的治疗方案。患者不参加MDT会议,但会议中做出的治疗建议会直接影响患者与其责任医生之间的决策过程。尽管研究表明,不考虑基于患者的信息可能导致不适当或不可接受的建议,进而延误治疗,但迄今为止尚无研究考虑患者对MDT或MDT会议的看法(或理解)。
对来自一个癌症中心的现有癌症患者(n = 9)进行了半结构化访谈,这些患者患有上消化道癌或妇科癌,同时对负责其护理的团队中的MDT成员(n = 12)也进行了访谈。使用框架方法对访谈记录进行主题分析。确定关键主题,并使用持续比较法确定和检查个体记录内部和之间、患者与团队成员样本内部和之间的共性与差异。
患者在MDT会议中参与决策过程或对其产生影响的机会有限。关键的解释因素包括,患者获得的关于MDT和MDT会议的信息有限且不一致,并且MDT成员在MDT和MDT会议的背景下对以患者为中心的定义各不相同。了解医学知识(通过自己目前/以前的工作或近亲的工作)的患者似乎对MDT有更深入的理解并能更好地接触到MDT。向患者介绍MDT和MDT会议的情况,让患者安心,这被视为一种“益处”。
有必要确保MDT流程既高效又以患者为中心。在护理的MDT模式下(即在讨论治疗建议时患者并不在场),如何落实“没有我参与,就没有关于我的决定”这一理念,需要进一步思考。需要采用方法确保患者积极融入MDT流程,以确保患者在参与方面能够做出明智的选择,并确保建议基于现有的最佳患者信息和临床证据。